|
Jun 4
|
FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble
|
|
Jun 3
|
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma
|
|
Jun 3
|
GSK Stock Slumps on Zantac Setback
|
|
Jun 3
|
Oil price slumps by 4pc despite Opec cuts
|
|
Jun 3
|
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward
|
|
Jun 3
|
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
|
|
Jun 3
|
GSK stock sinks after court allows Zantac lawsuits to proceed
|
|
Jun 3
|
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
|
|
Jun 2
|
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
|
|
May 15
|
GSK PLC's Dividend Analysis
|
|
May 11
|
GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
|
|
May 9
|
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
|
|
May 9
|
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
|
|
May 7
|
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
|
|
May 6
|
GSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
|
|
May 5
|
GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript
|
|
May 2
|
GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 1
|
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
|
|
May 1
|
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
|
|
May 1
|
GSK raises profit guidance as vaccine demand grows
|